Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Kruse JL"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Medicine & Science in Sports & Exercise; Apr2005, Vol. 37 Issue 4, p703-704, 2p
Autor:
Brooks JO 3rd; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA., Kruse JL; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA., Kubicki A; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.; Department of Neurology, Ahmanson-Lovelace Brain Mapping Center, Geffen School of Medicine at the University of California, Los Angeles, CA, USA., Hellemann G; University of Alabama, Birmingham, AL, USA., Espinoza RT; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA., Irwin MR; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA., Narr KL; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.; Department of Neurology, Ahmanson-Lovelace Brain Mapping Center, Geffen School of Medicine at the University of California, Los Angeles, CA, USA.
Publikováno v:
Psychological medicine [Psychol Med] 2024 Jan; Vol. 54 (1), pp. 108-116. Date of Electronic Publication: 2023 Jan 05.
Autor:
Kruse JL; Norman Cousins Center for Psychoneuroimmunology, Los Angeles, USA. jkruse@mednet.ucla.edu.; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, 300 UCLA Medical Plaza, Room 2273, Los Angeles, CA, 90095, USA. jkruse@mednet.ucla.edu., Boyle CC; Norman Cousins Center for Psychoneuroimmunology, Los Angeles, USA.; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, 300 UCLA Medical Plaza, Room 2273, Los Angeles, CA, 90095, USA., Olmstead R; Norman Cousins Center for Psychoneuroimmunology, Los Angeles, USA.; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, 300 UCLA Medical Plaza, Room 2273, Los Angeles, CA, 90095, USA., Breen EC; Norman Cousins Center for Psychoneuroimmunology, Los Angeles, USA.; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, 300 UCLA Medical Plaza, Room 2273, Los Angeles, CA, 90095, USA., Tye SJ; Queensland Brain Institute, The University of Queensland, Brisbane, Australia.; Department of Psychiatry & Psychology, Mayo Clinic, Rochester, USA.; Department of Psychiatry, University of Minnesota, Minneapolis, USA., Eisenberger NI; Norman Cousins Center for Psychoneuroimmunology, Los Angeles, USA.; Department of Psychology, University of California Los Angeles, Los Angeles, USA., Irwin MR; Norman Cousins Center for Psychoneuroimmunology, Los Angeles, USA.; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, 300 UCLA Medical Plaza, Room 2273, Los Angeles, CA, 90095, USA.
Publikováno v:
Scientific reports [Sci Rep] 2022 Jul 24; Vol. 12 (1), pp. 12627. Date of Electronic Publication: 2022 Jul 24.
Autor:
Kruse JL; Cousins Center for Psychoneuroimmunology, United States; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States. Electronic address: jkruse@mednet.ucla.edu., Olmstead R; Cousins Center for Psychoneuroimmunology, United States; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States., Hellemann G; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States., Breen EC; Cousins Center for Psychoneuroimmunology, United States; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States., Tye SJ; Queensland Brain Institute, The University of Queensland, Australia; Department of Psychiatry & Psychology, Mayo Clinic, United States; Department of Psychiatry, University of Minnesota, United States., Brooks JO 3rd; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States., Wade B; Department of Neurology, University of California at Los Angeles, Los Angeles, CA, United States., Congdon E; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States., Espinoza R; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States., Narr KL; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States; Department of Neurology, University of California at Los Angeles, Los Angeles, CA, United States., Irwin MR; Cousins Center for Psychoneuroimmunology, United States; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States.
Publikováno v:
Journal of psychiatric research [J Psychiatr Res] 2021 Aug; Vol. 140, pp. 350-356. Date of Electronic Publication: 2021 Jun 09.
Autor:
Brooks JO; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, California.; Corresponding author: John O. Brooks III, PhD, MD (john.brooks@ucla.edu)., Kruse JL; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, California.
Publikováno v:
The Journal of clinical psychiatry [J Clin Psychiatry] 2021 Apr 27; Vol. 82 (3). Date of Electronic Publication: 2021 Apr 27.
Autor:
Kruse JL; Cousins Center for Psychoneuroimmunology, University of California at Los Angeles, Los Angeles, CA, USA. jkruse@mednet.ucla.edu.; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Los Angeles, CA, USA. jkruse@mednet.ucla.edu., Vasavada MM; Department of Neurology, University of California at Los Angeles, Los Angeles, CA, USA., Olmstead R; Cousins Center for Psychoneuroimmunology, University of California at Los Angeles, Los Angeles, CA, USA.; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Los Angeles, CA, USA., Hellemann G; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Los Angeles, CA, USA., Wade B; Department of Neurology, University of California at Los Angeles, Los Angeles, CA, USA., Breen EC; Cousins Center for Psychoneuroimmunology, University of California at Los Angeles, Los Angeles, CA, USA.; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Los Angeles, CA, USA., Brooks JO; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Los Angeles, CA, USA., Congdon E; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Los Angeles, CA, USA., Espinoza R; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Los Angeles, CA, USA., Narr KL; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Los Angeles, CA, USA.; Department of Neurology, University of California at Los Angeles, Los Angeles, CA, USA., Irwin MR; Cousins Center for Psychoneuroimmunology, University of California at Los Angeles, Los Angeles, CA, USA.; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Los Angeles, CA, USA.
Publikováno v:
Translational psychiatry [Transl Psychiatry] 2021 Mar 15; Vol. 11 (1), pp. 167. Date of Electronic Publication: 2021 Mar 15.
Autor:
Volle DC; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. Electronic address: DCVolle@mednet.ucla.edu., Marder KG; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA., McKeon A; Departments of Neurology, Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Brooks JO; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA., Kruse JL; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Publikováno v:
General hospital psychiatry [Gen Hosp Psychiatry] 2021 Jan-Feb; Vol. 68, pp. 25-34. Date of Electronic Publication: 2020 Nov 13.
Autor:
Kruse JL; Cousins Center for Psychoneuroimmunology, United States; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States. Electronic address: jkruse@mednet.ucla.edu., Olmstead R; Cousins Center for Psychoneuroimmunology, United States; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States., Hellemann G; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States., Wade B; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States; Department of Neurology, University of California at Los Angeles, Los Angeles, CA, United States., Jiang J; Cousins Center for Psychoneuroimmunology, United States; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States., Vasavada MM; Department of Neurology, University of California at Los Angeles, Los Angeles, CA, United States., Brooks Iii JO; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States., Congdon E; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States., Espinoza R; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States., Narr KL; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States; Department of Neurology, University of California at Los Angeles, Los Angeles, CA, United States., Irwin MR; Cousins Center for Psychoneuroimmunology, United States; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, United States.
Publikováno v:
Brain, behavior, and immunity [Brain Behav Immun] 2020 Oct; Vol. 89, pp. 59-66. Date of Electronic Publication: 2020 May 29.
Autor:
Kruse JL; Cousins Center for Psychoneuroimmunology, University of California Los Angeles, United States; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, United States., Cho JH; Cousins Center for Psychoneuroimmunology, University of California Los Angeles, United States; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, United States. Electronic address: hjcho@mednet.ucla.edu., Olmstead R; Cousins Center for Psychoneuroimmunology, University of California Los Angeles, United States; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, United States., Hwang L; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, United States; Pasarow Mass Spectrometry Laboratory, University of California Los Angeles, United States., Faull K; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, United States; Pasarow Mass Spectrometry Laboratory, University of California Los Angeles, United States., Eisenberger NI; Cousins Center for Psychoneuroimmunology, University of California Los Angeles, United States; Department of Psychology, University of California Los Angeles, United States., Irwin MR; Cousins Center for Psychoneuroimmunology, University of California Los Angeles, United States; Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, United States.
Publikováno v:
Psychoneuroendocrinology [Psychoneuroendocrinology] 2019 Nov; Vol. 109, pp. 104371. Date of Electronic Publication: 2019 Jul 03.